ZEAL logo

Zealand Pharma A/S (ZEAL) EBITDA

Annual EBITDA

-$156.35 M
-$34.68 M-28.51%

December 31, 2021

Summary

Performance

1-Year Change

-28.51%

3-Year Change

-253.11%

5-Year Change

-299.54%

15-Year Change

-299.54%

ZEAL EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$102.12 M
ZEAL annual EBITDA is currently -253.11% below its historical high of $102.12 million

3-Year Low

-$156.35 M
ZEAL annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
ZEAL previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
ZEAL next annual earnings announcement has not yet been scheduled

OtherZEALprofitabilitymetrics:

Annual Revenue

$17.27 M
ZEAL annual revenue is $17.27 million

Annual Net Income

-$162.01 M
ZEAL annual net profit is -$162.01 million

Annual EBIT

-$162.76 M
ZEAL annual earnings before interest & taxes is -$162.76 million

Annual EPS

-$3.78
ZEAL annual earnings per share is -$3.78

Quarterly EBITDA

-$19.40 M
+$41.38 M+68.08%

September 1, 2022

Summary

Performance

3-Month Change

+68.08%

1-Year Change

+12.55%

3-Year Change

-14.21%

5-Year Change

-222.61%

ZEAL Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$156.29 M
ZEAL quarterly EBITDA is currently -112.41% below its historical high of $156.29 million

3-Year Low

-$60.78 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2022
ZEAL previous earnings announcement was published on Sep 1, 2022

Next Quarterly Earnings Report Date

N/A
ZEAL next earnings announcement has not yet been scheduled

OtherZEALprofitabilitymetrics:

Quarterly Revenue

$5.92 M
ZEAL quarterly revenue is $5.92 million

Quarterly Net Income

-$20.08 M
ZEAL quarterly net profit is -$20.08 million

Quarterly EBIT

-$19.40 M
ZEAL quarterly earnings before interest & taxes is -$19.40 million

Quarterly EPS

-$0.43
ZEAL quarterly earnings per share is -$0.43

TTM EBITDA

-$134.28 M
+$2.78 M+2.03%

September 1, 2022

Summary

Performance

3-Month Change

+2.03%

1-Year Change

+21.08%

3-Year Change

-56.37%

5-Year Change

-56.37%

ZEAL TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$104.85 M
ZEAL TTM EBITDA is currently -228.08% below its historical high of $104.85 million

3-Year Low

-$141.58 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2022
ZEAL previous earnings announcement was published on Sep 1, 2022

Next Quarterly Earnings Report Date

N/A
ZEAL next earnings announcement has not yet been scheduled

OtherZEALprofitabilitymetrics:

TTM Revenue

$14.32 M
ZEAL TTM revenue is $14.32 million

TTM Net Income

-$166.74 M
ZEAL TTM net profit is -$166.74 million

TTM EBIT

-$135.74 M
ZEAL TTM earnings before interest & taxes is -$135.74 million

TTM EPS

-$3.79
ZEAL TTM earnings per share is -$3.79

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$156.35 M
ZEAL annual EBITDA is -$156.35 million

Annual Net Income

-$162.01 M
ZEAL annual net profit is -$162.01 million

Annual Interest Expense

$651.00 K
ZEAL annual interest expense is $651.00 thousand

Annual Income Tax

-$628.40 K
ZEAL annual income tax is -$628.40 thousand

Annual D&A

$6.40 M
ZEAL annual depreciation & amortization is $6.40 million

ZEAL EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-28.5%+12.6%+21.1%
3 y3 years-253.1%-14.2%-56.4%
5 y5 years-299.5%-222.6%-56.4%

ZEAL EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high+213.3%+6.9%+5.4%
5 y5-year+86.3%at low+128.1%+213.3%+69.3%+36.6%
alltimeall time-253.1%at low-112.4%+213.3%-228.1%+36.6%

Zealand Pharma A/S EBITDA History

DateAnnualQuarterlyTTM
Sep 2022
-
-$19.40 M(-68.1%)
-$134.28 M(-2.0%)
Jun 2022
-
-$60.78 M(+168.4%)
-$137.07 M(+9.2%)
Mar 2022
-
-$22.65 M(-28.0%)
-$125.56 M(-11.3%)
Dec 2021
-$156.35 M(+28.5%)
-$31.46 M(+41.8%)
-$141.58 M(-16.8%)
Sep 2021
-
-$22.18 M(-55.0%)
-$170.16 M(-7.2%)
Jun 2021
-
-$49.27 M(+27.4%)
-$183.43 M(+28.6%)
Mar 2021
-
-$38.67 M(-35.6%)
-$142.66 M(+9.4%)
Dec 2020
-$121.67 M(+45.0%)
-$60.03 M(+69.3%)
-$130.38 M(+33.3%)
Sep 2020
-
-$35.46 M(+316.9%)
-$97.78 M(+23.3%)
Jun 2020
-
-$8.51 M(-67.8%)
-$79.31 M(-13.4%)
Mar 2020
-
-$26.38 M(-3.8%)
-$91.59 M(+6.7%)
Dec 2019
-$83.94 M(-182.2%)
-$27.44 M(+61.5%)
-$85.87 M(+2.2%)
Sep 2019
-
-$16.99 M(-18.3%)
-$84.04 M(-194.2%)
Jun 2019
-
-$20.79 M(+0.6%)
$89.23 M(-3.8%)
Mar 2019
-
-$20.67 M(-19.3%)
$92.71 M(-6.4%)
Dec 2018
$102.12 M(-360.9%)
-$25.61 M(-116.4%)
$99.09 M(-5.5%)
Sep 2018
-
$156.29 M(-1003.0%)
$104.85 M(-282.5%)
Jun 2018
-
-$17.31 M(+21.2%)
-$57.46 M(+6.0%)
Mar 2018
-
-$14.28 M(-28.0%)
-$54.20 M(+34.6%)
Dec 2017
-$39.13 M(+116.1%)
-$19.85 M(+230.1%)
-$40.28 M(+157.0%)
Sep 2017
-
-$6.01 M(-57.2%)
-$15.67 M(+38.5%)
Jun 2017
-
-$14.05 M(+3758.1%)
-$11.31 M(+10.7%)
Mar 2017
-
-$364.20 K(-107.7%)
-$10.22 M(-47.0%)
Dec 2016
-$18.11 M(+49.8%)
$4.76 M(-387.3%)
-$19.27 M(+38.4%)
Sep 2016
-
-$1.66 M(-87.2%)
-$13.92 M(-26.2%)
Jun 2016
-
-$12.95 M(+37.6%)
-$18.85 M(+21.9%)
Mar 2016
-
-$9.42 M(-193.2%)
-$15.47 M(+17.4%)
DateAnnualQuarterlyTTM
Dec 2015
-$12.09 M(+5.0%)
$10.11 M(-253.4%)
-$13.18 M(-61.9%)
Sep 2015
-
-$6.59 M(-31.2%)
-$34.57 M(+37.2%)
Jun 2015
-
-$9.57 M(+34.3%)
-$25.20 M(+3.3%)
Mar 2015
-
-$7.13 M(-36.8%)
-$24.40 M(+103.8%)
Dec 2014
-$11.51 M(-63.6%)
-$11.28 M(-506.0%)
-$11.98 M(+32.3%)
Sep 2014
-
$2.78 M(-131.7%)
-$9.05 M(-49.5%)
Jun 2014
-
-$8.77 M(-265.5%)
-$17.90 M(+3.4%)
Mar 2014
-
$5.30 M(-163.4%)
-$17.32 M(-47.0%)
Dec 2013
-$31.64 M(-537.1%)
-$8.36 M(+37.6%)
-$32.68 M(-3.0%)
Sep 2013
-
-$6.08 M(-25.8%)
-$33.71 M(+22.1%)
Jun 2013
-
-$8.19 M(-18.6%)
-$27.60 M(+80.3%)
Mar 2013
-
-$10.06 M(+7.3%)
-$15.31 M(-335.6%)
Dec 2012
$7.24 M(+163.9%)
-$9.38 M(<-9900.0%)
$6.50 M(-51.0%)
Sep 2012
-
$28.90 K(-99.3%)
$13.25 M(+38.4%)
Jun 2012
-
$4.10 M(-65.1%)
$9.58 M(-58.8%)
Mar 2012
-
$11.74 M(-547.3%)
$23.23 M(+483.6%)
Dec 2011
$2.74 M(-115.2%)
-$2.63 M(-28.0%)
$3.98 M(-182.9%)
Sep 2011
-
-$3.65 M(-120.5%)
-$4.80 M(-55.2%)
Jun 2011
-
$17.76 M(-336.5%)
-$10.71 M(-51.9%)
Mar 2011
-
-$7.51 M(-34.2%)
-$22.27 M(+16.8%)
Dec 2010
-$18.02 M(+26.3%)
-$11.41 M(+19.3%)
-$19.06 M(+149.1%)
Sep 2010
-
-$9.56 M(-254.0%)
-$7.65 M(-501.5%)
Jun 2010
-
$6.21 M(-244.3%)
$1.91 M(-144.3%)
Mar 2010
-
-$4.30 M
-$4.30 M
Dec 2009
-$14.27 M(+139.9%)
-
-
Dec 2008
-$5.95 M(-48.3%)
-
-
Dec 2007
-$11.50 M
-
-

FAQ

  • What is Zealand Pharma A/S annual EBITDA?
  • What is the all time high annual EBITDA for Zealand Pharma A/S?
  • What is Zealand Pharma A/S annual EBITDA year-on-year change?
  • What is Zealand Pharma A/S quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Zealand Pharma A/S?
  • What is Zealand Pharma A/S quarterly EBITDA year-on-year change?
  • What is Zealand Pharma A/S TTM EBITDA?
  • What is the all time high TTM EBITDA for Zealand Pharma A/S?
  • What is Zealand Pharma A/S TTM EBITDA year-on-year change?

What is Zealand Pharma A/S annual EBITDA?

The current annual EBITDA of ZEAL is -$156.35 M

What is the all time high annual EBITDA for Zealand Pharma A/S?

Zealand Pharma A/S all-time high annual EBITDA is $102.12 M

What is Zealand Pharma A/S annual EBITDA year-on-year change?

Over the past year, ZEAL annual EBITDA has changed by -$34.68 M (-28.51%)

What is Zealand Pharma A/S quarterly EBITDA?

The current quarterly EBITDA of ZEAL is -$19.40 M

What is the all time high quarterly EBITDA for Zealand Pharma A/S?

Zealand Pharma A/S all-time high quarterly EBITDA is $156.29 M

What is Zealand Pharma A/S quarterly EBITDA year-on-year change?

Over the past year, ZEAL quarterly EBITDA has changed by +$2.78 M (+12.55%)

What is Zealand Pharma A/S TTM EBITDA?

The current TTM EBITDA of ZEAL is -$134.28 M

What is the all time high TTM EBITDA for Zealand Pharma A/S?

Zealand Pharma A/S all-time high TTM EBITDA is $104.85 M

What is Zealand Pharma A/S TTM EBITDA year-on-year change?

Over the past year, ZEAL TTM EBITDA has changed by +$35.87 M (+21.08%)